(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇

产品供应(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇

  • 发布日期：2022-08-11
  • 有效期限：30天
常州市普华化工科技有限公司 VIP
C52H49N5O5
823.98
回上一页
联系供应商
在线询盘 打印本页
详细信息
  • ;恩替卡韦中间体N5;恩替卡韦-5;恩替卡韦中间体5;E5;(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇(N5);
  • (2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanol
  • ;(2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-2-a(benzyloxymethyl)cyclopentanol;(2R,3S,5S)-3-(Benzyloxy)-5-(6-benzyloxy)-2-(4-methyoxyphenyl)diphenylmethylamino)-9H-purin-9-yl)-2-benzyloxymethyl)cyclopentanol;Entecavir intermediate N5;(1S,2S,3S,5S)-3-(benzyloxy)-5-(6-(benzyloxy)-2-((4-methoxyphenyl)diphenylmethylamino)-9H-purin-9-yl)-2-((4-methylbenzyloxy)methyl)cyclopentanol;Entecavir intermediate 5;Intermediate of Entecavir 3;(1S,2S,3S,5S)-3-(benzyloxy-5-(6-(benzyloxy)-2-(diphenyl(p-tolylamino)methylamino)-1H-purin-9(6H)-yl-2-(benzyloxymethyl)cyclopentanol;(2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanol (E5);E5;(2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl) diphenylmethyl]amino]-6- (phenylmethoxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanol;(1S,2S,3S,5S)-3-(benzyloxy)-5-(6-(benzyloxy)-2-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-9-yl)-2-((benzyloxy)methyl)cyclopentanol;
  • InChI=1/C52H49N5O5/c1-59-43-29-27-42(28-30-43)52(40-23-13-5-14-24-40,41-25-15-6-16-26-41)56-51-54-49-47(50(55-51)62-34-39-21-11-4-12-22-39)53-36-57(49)45-31-46(61-33-38-19-9-3-10-20-38)44(48(45)58)35-60-32-37-17-7-2-8-18-37/h2-30,36,44-46,48,58H,31-35H2,1H3,(H,54,55,56)/t44-,45-,46-,48?/m0/s1

免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，化工网对此不承担任何保证责任。我们原则上建议您选择化工网高级会员或VIP会员。